1,205
Participants
Start Date
January 31, 2017
Primary Completion Date
December 31, 2017
Study Completion Date
January 31, 2018
Eravacycline
Ertapenem
Placebo
Levofloxacin
Columbus
Fullerton
Los Angeles
Torrance
Coral Gables
Doral
Miami
St Louis
Las Vegas
Baytown
Graz
Linz
Salzburg
Pleven
Plovdiv
Razgrad
Rousse
Smyadovo
Sofia
Varna
Veliko Tarnovo
Tallinn
Tartu
Võru
K'ut'aisi
T'bilisi
Baja
Budapest
Miskolc
Nagykanizsa
Nyíregyháza
Sopron
Szentes
Tatabánya
Jelgava
Riga
Valmiera
Chisinau
Brasov
Bucharest
Craiova
Oradea
Arkhangelsk
Moscow
Pyatigorsk
Rostov-on-the-Don
Saint Petersburg
Smolensk
Vsevolozhsk
Yaroslavl
Nitra
Poprad
Prešov
Svidník
Žilina
Chernihiv
Chernivtsi
Dnipro
Ivano-Frankivsk
Kharkiv
Kyiv
Lviv
Mykolaiv
Odesa
Poltava
Uzhhorod
Vinnytsia
Zaporizhia
Zhytomyr
Tetraphase Pharmaceuticals, Inc
INDUSTRY